Skip to Main Content

Paper Details

COVID-19 neutralizing antibodies predict disease severity and survival.
medRxiv
18
2020
COVID, COVID-19, D614G, RBD, SARS-CoV, SARS-CoV-2, WIV1, WIV1-CoV, anti-RBD IgG, coronavirus pandemics, lymphopenia, patient, patients
Author NameAffiliation
Wilfredo F Garcia-BeltranMassachusetts General Hospital
Galit AlterRagon Institute of MGH
Richelle C CharlesMassachusetts General Hospital
Jochen K LennerzMassachusetts General Hospital
Anthony J IafrateMassachusetts General Hospital
  • 1 - 5

Datasets

Release 1.2